Home » RANBAXY STARTS CANADIAN OPERATIONS
RANBAXY STARTS CANADIAN OPERATIONS
Ranbaxy Laboratories today announced the launch of a wholly-owned subsidiary Ranbaxy Pharmaceuticals Canada Inc (RPCI). According to a release issued by Ranbaxy to the BSE today, RPCI has already received approvals to sell eight products in Canada in the anti-infective, diabetes and cardiovascular segment including Carvedilol, Ciprofloxacin, Citalopram, Domperidone, Lovastatin, Atenolol, Metformin and Zepiclone.
Business Standard (http://www.business-standard.com/bsonline/storypage.php?bKeyFlag=BO&autono=11496)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May